Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
Treatment Advances in Generalized Myasthenia Gravis: Addressing the Nuances of its Underlying Immunopathology
Vera Bril, MD
Nicholas J. Silvestri, MD
Hans Katzberg, MD
Diagnostic Advances in gMG: Effective Tools and Techniques
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
Managing Side Effects in FcRn Therapy: Best Practices for gMG
Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
May 01, 2025
Washington, DC, District of Columbia
Personalizing Care Within the RCC Treatment Paradigm
Eric Jonasch, MD
Brad McGregor, MD
Ulka Vaishampayan, MBBS
Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles
Ocular to Generalized MG: How and Why the Disease Evolves
Preventing Myasthenic Crisis: Early Signs and Critical Interventions
Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management
What’s New in Glaucoma Topical Therapies?
Justin Schweitzer, OD, FAAO
Sarah H. Van Tassel, MD
What’s New in Schlemm’s Canal MIGS?
Paul Petrakos, DO, MS
I. Paul Singh, MD
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
Jonathan Strober, MD
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
April 29, 2025
San Diego, California
What’s New in Suprachoroidal MIGS?
3D Heads-Up Visualization: Tips for Getting Started in Glaucoma Surgery
Evolving Strategies for Sustained-Release Glaucoma Treatments
Effective MIGS for Optimal IOP Control: A Case-Based Approach
Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
Collaborative Insights to Solve the Puzzle of Bladder Cancer
Daniel P. Petrylak, MD
Elizabeth R. Plimack, MD, MS, FASCO
Evan Y. Yu, MD
3D Heads-Up Visualization: Cases in Glaucoma Surgery
Timing of Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
Sandra Swain, MD
Virginia Kaklamani, MD
Recent Updates on Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
Future Directions of Ovarian Function Suppression: Answering Unmet Needs in Premenopausal HR+ Early-Stage Breast Cancer
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.